BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 17787036)

  • 1. Design of recombinant antibody microarrays for complex proteome analysis: choice of sample labeling-tag and solid support.
    Wingren C; Ingvarsson J; Dexlin L; Szul D; Borrebaeck CA
    Proteomics; 2007 Sep; 7(17):3055-65. PubMed ID: 17787036
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Multiplexed Nucleic Acid Programmable Protein Arrays.
    Yu X; Song L; Petritis B; Bian X; Wang H; Viloria J; Park J; Bui H; Li H; Wang J; Liu L; Yang L; Duan H; McMurray DN; Achkar JM; Magee M; Qiu J; LaBaer J
    Theranostics; 2017; 7(16):4057-4070. PubMed ID: 29109798
    [No Abstract]   [Full Text] [Related]  

  • 3. Advancing translational research with next-generation protein microarrays.
    Yu X; Petritis B; LaBaer J
    Proteomics; 2016 Apr; 16(8):1238-50. PubMed ID: 26749402
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Photocleavage-based affinity purification and printing of cell-free expressed proteins: application to proteome microarrays.
    Lim M; Rothschild KJ
    Anal Biochem; 2008 Dec; 383(1):103-15. PubMed ID: 18762158
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Protein microarrays: a chance to study microorganisms?
    Kreutzberger J
    Appl Microbiol Biotechnol; 2006 Apr; 70(4):383-90. PubMed ID: 16489452
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Functional proteomics based on protein microarray technology for biomedical research.
    Juanes-Velasco P; Arias-Hidalgo C; Landeira-Viñuela A; Nuño-Soriano A; Fuentes-Vacas M; Góngora R; Hernández ÁP; Fuentes M
    Adv Protein Chem Struct Biol; 2024; 138():49-65. PubMed ID: 38220432
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Protein arrays and perspectives of medical applications].
    Sakanyan V; Arnaud MC
    Ing Rech Biomed; 2007; 28(5):187-193. PubMed ID: 32572340
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Identification of a serum biomarker signature associated with metastatic prostate cancer.
    Kuci Emruli V; Liljedahl L; Axelsson U; Richter C; Theorin L; Bjartell A; Lilja H; Donovan J; Neal D; Hamdy FC; Borrebaeck CAK
    Proteomics Clin Appl; 2021 May; 15(2-3):e2000025. PubMed ID: 33580906
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Fluorescence Signal Enhancement in Antibody Microarrays Using Lightguiding Nanowires.
    Verardo D; Liljedahl L; Richter C; Agnarsson B; Axelsson U; Prinz CN; Höök F; Borrebaeck CAK; Linke H
    Nanomaterials (Basel); 2021 Jan; 11(1):. PubMed ID: 33467141
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Tumor tissue protein signatures reflect histological grade of breast cancer.
    Skoog P; Ohlsson M; Fernö M; Rydén L; Borrebaeck CAK; Wingren C
    PLoS One; 2017; 12(6):e0179775. PubMed ID: 28650989
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Evaluation of Solid Supports for Slide- and Well-Based Recombinant Antibody Microarrays.
    Gerdtsson AS; Dexlin-Mellby L; Delfani P; Berglund E; Borrebaeck CA; Wingren C
    Microarrays (Basel); 2016 Jun; 5(2):. PubMed ID: 27600082
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Plasma protein profiling in a stage defined pancreatic cancer cohort - Implications for early diagnosis.
    Gerdtsson AS; Wingren C; Persson H; Delfani P; Nordström M; Ren H; Wen X; Ringdahl U; Borrebaeck CA; Hao J
    Mol Oncol; 2016 Oct; 10(8):1305-16. PubMed ID: 27522951
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Technical Advances of the Recombinant Antibody Microarray Technology Platform for Clinical Immunoproteomics.
    Delfani P; Dexlin Mellby L; Nordström M; Holmér A; Ohlsson M; Borrebaeck CA; Wingren C
    PLoS One; 2016; 11(7):e0159138. PubMed ID: 27414037
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A Multicenter Trial Defining a Serum Protein Signature Associated with Pancreatic Ductal Adenocarcinoma.
    Gerdtsson AS; Malats N; Säll A; Real FX; Porta M; Skoog P; Persson H; Wingren C; Borrebaeck CA
    Int J Proteomics; 2015; 2015():587250. PubMed ID: 26587286
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Nanobodies and recombinant binders in cell biology.
    Helma J; Cardoso MC; Muyldermans S; Leonhardt H
    J Cell Biol; 2015 Jun; 209(5):633-44. PubMed ID: 26056137
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Identification of plasma protein profiles associated with risk groups of prostate cancer patients.
    Nordström M; Wingren C; Rose C; Bjartell A; Becker C; Lilja H; Borrebaeck CA
    Proteomics Clin Appl; 2014 Dec; 8(11-12):951-62. PubMed ID: 25196118
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Proteomics-based dissection of human endoderm progenitors by differential cell capture on antibody array.
    Sharivkin R; Walker MD; Soen Y
    Mol Cell Proteomics; 2012 Sep; 11(9):586-95. PubMed ID: 22580589
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Fluorescent labeling of antibody fragments using split GFP.
    Ferrara F; Listwan P; Waldo GS; Bradbury AR
    PLoS One; 2011; 6(10):e25727. PubMed ID: 21998685
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Molecular serum portraits in patients with primary breast cancer predict the development of distant metastases.
    Carlsson A; Wingren C; Kristensson M; Rose C; Fernö M; Olsson H; Jernström H; Ek S; Gustavsson E; Ingvar C; Ohlsson M; Peterson C; Borrebaeck CA
    Proc Natl Acad Sci U S A; 2011 Aug; 108(34):14252-7. PubMed ID: 21844363
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Proteomic analysis and discovery using affinity proteomics and mass spectrometry.
    Olsson N; Wingren C; Mattsson M; James P; O'Connell D; Nilsson F; Cahill DJ; Borrebaeck CA
    Mol Cell Proteomics; 2011 Oct; 10(10):M110.003962. PubMed ID: 21673276
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.